• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO CLINICAL DIAGNOSTICS REAGENT RED BLOOD CELLS 0.8% RESOLVE PANEL A

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO CLINICAL DIAGNOSTICS REAGENT RED BLOOD CELLS 0.8% RESOLVE PANEL A Back to Search Results
Catalog Number 6902317
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/02/2018
Event Type  malfunction  
Manufacturer Narrative
Ortho performed retain testing, batch review, complaint review by lot, donor history, and donor complaint review.Based upon the results of this investigation, the reported customer issue was unable to be confirmed.All results were satisfactory.Sample was not returned to ortho for further investigation.(b)(4).
 
Event Description
Account reports one patient with no previous history with anti-big e.Patient was positive (1+) with the big e positive cell on 0.8% selectogen, but failed to react with any big e positive cells on 0.8% resolve panel a lot vra296.Account then performed 0.8% resolve panel b and all big e positive cells reacted 1+.Anti-igg card was used.No erroneous results released.Only big e negative blood was selected for transfusion.No harm came to patient.Issue started on: (b)(6) 2018.Frequency: one patient.Methodology used: manual gel.Incubation time (for manual test only): 15 minutes.Reaction grade obtained: 1+ for the big e positive cells on 0.8% selectogen and 0.8% resolve panel b, no reactivity with big e positive cells on vra296.Customer was expecting: all big e positive cells to be positive.Test repeated: yes.Account did repeat the big e positive cells on 0.8% resolve panel a - they did not extend the incubation time.Result obtained by repeating: they were still negative.Method used to repeat: manual gel.Daily qc performed and found to be acceptable.Sample type: edta plasam.Cards /cassettes/rbc storage condition temperature: per ifu.Visual appearance before use: all reagents have a normal appearance prior to use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REAGENT RED BLOOD CELLS 0.8% RESOLVE PANEL A
Type of Device
REAGENT RED BLOOD CELLS
Manufacturer (Section D)
ORTHO CLINICAL DIAGNOSTICS
1001 route 202
raritan NJ 08869
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
1001 route 202
raritan NJ 08869
Manufacturer Contact
matthew p wictome
1001 route 202
raritan, NJ 08869
9082188223
MDR Report Key7369118
MDR Text Key103923179
Report Number2250051-2018-00030
Device Sequence Number1
Product Code KSZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Medical Technologist
Type of Report Initial
Report Date 03/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Medical Technologist
Device Expiration Date03/27/2018
Device Catalogue Number6902317
Device Lot NumberVRA296
Other Device ID Number10758750007677
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/02/2018
Initial Date FDA Received03/26/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/23/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-